Growth inhibition and synergistic induction of apoptosis by zoledronate and dexamethasone in human myeloma cell lines-Reference-Cited by-同舟云学术

Growth inhibition and synergistic induction of apoptosis by zoledronate and dexamethasone in human myeloma cell lines

Published:2000-04-28 Issue:5 Volume:14 Page:841-844
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Tassone P,Forciniti S,Galea E,Morrone G,Turco MC,Martinelli V,Tagliaferri P,Venuta S

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2401770.pdf

Reference27 articles.

1. Mundy GR, Bertoline DR . Bone destruction and hypercalcemia in plasma cell myeloma Semin Oncol 1986 13: 291–299

2. Bataille R, Chappard D, Basle M . Excessive bone resorption in human plasmacytomas: direct induction by tumor cells in vivo Br J Haematol 1995 90: 721–724

3. Stashenko P, Dewhirst FE, Peros WJ, Ago JM . Synergistic interactions between interleukin-1, tumor necrosis factor and lymphotoxin in bone resorption J Immunol 1987 138: 1464–1468

4. Fleisch H . Bisphophonates: pharmacology and use in the treatment of tumor-induced hypercalcemia and metastatic bone disease Drugs 1991 42: 919–944

5. Coleman RE, Purohit OP . Osteoclast inhibitor for the treatment of bone metatases Cancer Treat Rev 1993 19: 79–103

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-Angiogenic Activity of Drugs in Multiple Myeloma;Cancers;2023-03-27

2. Targeting Notch Inhibitors to the Myeloma Bone Marrow Niche Decreases Tumor Growth and Bone Destruction without Gut Toxicity;Cancer Research;2021-08-04

3. Near-infrared light-controllable on-demand antibiotics release using thermo-sensitive hydrogel-based drug reservoir for combating bacterial infection;Biomaterials;2019-01

4. Minodronic Acid in Combination with γδT Cells Induces Apoptosis of Non-small Cell Lung Carcinoma Cell Lines;Anticancer Research;2016-11-01

5. DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine;Oncotarget;2016-06-09